SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

248 hedge funds and large institutions have $4.71B invested in Sage Therapeutics in 2018 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 91 increasing their positions, 88 reducing their positions, and 58 closing their positions.

Holders
248
Holders Change
-26
Holders Change %
-9.49%
% of All Funds
5.53%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.13%
New
32
Increased
91
Reduced
88
Closed
58
Calls
$129M
Puts
$93.6M
Net Calls
+$35.8M
Net Calls Change
+$34.8M

Top Buyers

1
PHS
1
PFM Health Sciences
California
$48.4M
2
EAM
2
Eventide Asset Management
Massachusetts
$89.7M
3
BB
3
BB Biotech
Switzerland
$132M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$175M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$768M

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
RCM
2
RA Capital Management
Massachusetts
$0
3
BlackRock
3
BlackRock
New York
$240M
4
Millennium Management
4
Millennium Management
New York
$12.3M
5
FCM
5
Farallon Capital Management
California
$38.3M
Name Market Value Shares Shares
Change 		Shares
Change %
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$768M 8,020,411 +267,777 +3%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$674M 7,033,076 +33,432 +0.5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$385M 4,022,470 -63,342 -2%
BlackRock
4
BlackRock
New York
$240M 2,510,491 -305,919 -11%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$184M 1,921,835 -48,935 -2%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$175M 1,831,437 +283,077 +18%
O
7
OppenheimerFunds
New York
$138M 1,438,424 -145,196 -9%
BB
8
BB Biotech
Switzerland
$132M 1,375,229 +303,856 +28%
State Street
9
State Street
Massachusetts
$102M 1,060,834 +55,289 +5%
Franklin Resources
10
Franklin Resources
California
$99.9M 1,042,955 +92,182 +10%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$91.1M 951,542 +15,484 +2%
EAM
12
Eventide Asset Management
Massachusetts
$89.7M 936,000 +442,000 +89%
PAI
13
Palo Alto Investors
California
$81.5M 850,977 +10,605 +1%
Jennison Associates
14
Jennison Associates
New York
$81M 845,664 +35,440 +4%
EAM
15
Eagle Asset Management
Florida
$62M 647,342 -6,672 -1%
Invesco
16
Invesco
Georgia
$60.8M 635,149 +57,655 +10%
American Century Companies
17
American Century Companies
Missouri
$50.8M 530,095 +82,189 +18%
PHS
18
PFM Health Sciences
California
$48.4M 505,776 +505,776 New
CTA
19
Carillon Tower Advisers
Florida
$46.9M 489,822 +21 +0%
MWNA
20
Marshall Wace North America
New York
$46.6M 486,704 -2,444 -0.5%
AllianceBernstein
21
AllianceBernstein
Tennessee
$45.2M 471,529 +57,233 +14%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$44.8M 467,917 +32,033 +7%
Victory Capital Management
23
Victory Capital Management
Texas
$44.4M 463,541 +42,806 +10%
FCM
24
Farallon Capital Management
California
$38.3M 400,000 -225,000 -36%
Norges Bank
25
Norges Bank
Norway
$33.1M 345,282 +8,938 +3%
1
2 3 4 5